Susquehanna International Group, LLP Avrobio, Inc. Call Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	SELL	$1.22 - $1.62 $18,422 - $24,462	-15,100 Reduced 11.95%	111,300 $151,000
Q3 2023 Nov 14, 2023	BUY	$0.98 - $1.62 $123,872 - $204,768	126,400 New	126,400 $194,000
Q1 2022 May 16, 2022	SELL	$1.29 - $4.04 $16,125 - $50,500	-12,500 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.45 - $6.05 $2,760 - $4,840	-800 Reduced 6.02%	12,500 $48,000
Q1 2021 May 17, 2021	BUY	$10.54 - $19.3 $140,182 - $256,690	13,300 New	13,300 $169,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.